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Infectious disease modeling has played a prominent role in recent outbreaks, yet
integrating these analyses into public health decision-making has been challenging. We recommend establishing ‘outbreak science’ as an inter-disciplinary
ﬁeld to improve applied epidemic modeling.

The enduring threat of epidemics and the promise of models
In 2018–2019, the Ebola virus disease emergency in the Democratic Republic of Congo continues
to prompt fresh reﬂections on how to optimize epidemic response1. ‘Lessons learned’ from
previous outbreaks often focus on the development and deployment of medical countermeasures, such as vaccines and antivirals. However, additional tools can aid in outbreak
response. Mathematical and statistical modeling has repeatedly proven to be a valuable resource
in targeting outbreak response needs, and can inform the effective use of vaccines2, antivirals3,
and other countermeasures (e.g. school closures and social distancing). Despite this, and in
contrast to research and development of medical countermeasures, few efforts have been
coordinated to improve optimization of modeling and other outbreak data analyses during
public health emergencies caused by emerging infectious diseases.
Models played a prominent role in the 2014–2016 Ebola epidemic in West Africa. During the
ﬁrst half of the outbreak, public health operations were complicated by situational awareness
limited by sparse data availability from the affected countries4. Reports from the ground indicated that the outbreak was growing quickly, but uncertainty about the current and future
trajectory of the epidemic slowed mobilization of the public health response4. Faced with that
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uncertainty, decision makers incorporated information from
infectious disease models, with early forecasts indicating that
incidence would continue to grow rapidly unless aggressive
interventions were implemented. For example, a forecast generated by the CDC predicted up to 1.4 million Ebola cases with no
additional interventions or changes in community behavior5.
These forecasts likely contributed to the acceleration of the
international response and provided guidance for how resources
might be effectively deployed.
Nevertheless, the integration of those analyses into the
decision-making cycle for the Ebola 2014–2016 epidemic was not
seamless, a pattern repeated across many recent outbreaks,
including Zika6. Reasons for this vary. Modeling and outbreak
data analysis efforts typically occur in silos with limited communication of methods and data between model developers and
end users. Modeling “cross talk” across stakeholders within and
between countries is also typically limited, often occurring within
a landscape of legal and ethical uncertainty. Speciﬁcally, the ethics
of performing research using surveillance and health data7, limited knowledge of what types of questions models can help
inform, data sharing restrictions8, and the incentive in academia
to quickly publish modeling results in peer-reviewed journals
contribute to a complex collaborative environment with different
and sometimes conﬂicting stakeholder goals and priorities.
To remedy these challenges, we propose the establishment of
‘outbreak science’ as an inter-disciplinary ﬁeld to improve the
implementation of models and critical data analyses in epidemic
response. This new track of outbreak science describes the
functional use of models, clinical knowledge, laboratory results,
data science, statistics, and other advanced analytical methods
to speciﬁcally support public health decision making between and
during outbreak threats. Outbreak scientists work with decision
makers to turn outbreak data into actionable information
for decisions about how to anticipate the course of an outbreak,
allocate scarce resources, and prioritize and implement public
health interventions. Here, we make three speciﬁc recommendations to get the most out of modeling efforts during
outbreaks and epidemics. Together these recommendations
constitute the foundation of an integrative ﬁeld that is “outbreak
science”:
1: Be prepared: Establish functional model capability and
foster relationships before the emergency begins
In many of the recent communicable disease public health
emergencies, a suite of academic and government modelers
produced important analyses, but few were speciﬁcally tasked and
funded to do so in a coordinated, functional fashion. The reactive
(rather than prospective) mobilization of modelers and computational epidemiologists in public health emergencies is not new.
Rapid development and deployment of infectious disease models
was important during the 2009 inﬂuenza pandemic, chikungunya,
and SARS9–11. Models helped decision makers to understand the
likely trajectory of the outbreaks, the risk of international spread,
and the potential impact of interventions. Although identiﬁed as
inﬂuential at the time, few if any investments in permanent
capabilities to integrate such analyses into the decision-making
process have followed.
However, a few examples of successful partnerships between
modelers and decision makers may serve as inspiration. Small
teams exist in agencies in the US government such as at CDC,
BARDA and NIH. Similar examples exist in the UK with
expertise within government agencies and from academic entities,
for instance, Imperial College and the London School of Hygiene
and Tropical Medicine.
2

Leveraging these promising examples (not an exhaustive list),
we therefore recommend that epidemic modeling capability be
enhanced and honed not during rapidly-evolving public health
emergencies, but rather between major epidemics. Such approaches can leverage historical datasets and/or be developed using
routine communicable disease data. An excellent example of this
is the Epidemic Prediction Initiative (EPI) [https://predict.cdc.
gov], which has built a framework for open forecasting and
transparent evaluation and facilities participation through standardized data and forecast formats and community building12.
2: People and computation: Develop connections between
model developers and model users
Currently, limited information is available on how those on the
frontlines of public health perceive and use models in epidemic
decision-making. Understanding the functional relationship
between the public health end-users and model developers is
critical to improving capacity during outbreaks. A recent pilot
study (n = 29 respondents) in Australia suggests a disconnect
between model end-users and model developers, with overall
infrequent use of modeling in public health practice due to factors
such as a lack of in-house modeling expertise, variable trust and/
or comprehension of model outputs, and uncertainty regarding
whether models could answer the most important operational
questions on the most relevant temporal and spatial scale13.
Similarly, state and local health ofﬁcials in the US reported
reluctance in translating pandemic inﬂuenza epidemic models
into public health action, despite the respondents’ familiarity with
such models14. More recently, a limited evaluation of 39 inﬂuenza
public health practitioners from three US public health organizations indicated that approximately one in ﬁve had direct
communication with modelers, 67% felt that models should be
more relevant to public health questions, and 59% wanted more
frequent communication with model developers15.
But this relationship must also be a two-way street. Without
opportunities to gain experience, modelers do not necessarily
understand or anticipate the needs and preference of decision
makers. Improved communication and collaboration between the
two stakeholder groups would improve the quality and utility of
models and the decisions they support. This suggestion is not
novel, yet the need clearly remains in 201913,15. To improve these
connections, we advocate systematically measuring perceptions of
both model end-users and model developers to identify what are
the key barriers to functional model development and implementation. For example, stakeholder surveys, focus groups and
other qualitative data can identify whether the public health
priorities as interpreted by model developers are aligned with
end-users, whether end-users trust or prefer particular models (or
modelers) over others, and whether major gaps are present in
end-user modeling literacy and/or model developer
communication.
3: Modelers on the front-lines: Formalize ‘outbreak science’
by building capacity and supporting training and practice
opportunities
Developing and implementing epidemic models under the “fog of
war” is an enterprise far removed from the controlled conventional academic setting of epidemiology and biostatistics. We call
for cross-cutting outbreak science fellowship programs in which
epidemic modelers partner with experts from other disciplines
including clinicians, basic scientists, computational biologists,
veterinarians, entomologists, epidemiologists, environmental scientists, and those in operational public health. Ideally, these
programs would involve rotations in the ﬁeld to experience
challenges like rapidly changing information, varying quality of
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data, critical inter-personal relationships between and within
institutions, and evolving public health priorities. The CDC’s
Epidemic Intelligence Service program, a good model for training
public health practitioners in applied epidemiology, could serve as
a template for a similar program that provides academic modelers
and other stakeholders with training in applied infectious disease
modeling. Furthermore, training programs of this kind can
facilitate research opportunities, as called for in recommendation
#2, that investigate relationships and processes between modelers
and end users, document current challenges to model implementation during epidemic response, and identify best practices
needed to promote integration of modeling into public health.
Conclusion: Invest in functional modeling capability before
the emergency begins
To make outbreak modeling a more effective component of
decision-making during outbreaks requires a paradigm shift. To
be successful, building working relationships is as necessary as
building quantitative modeling capacity. Rather than waiting for
the next pandemic, we should use opportunities between pandemics to ﬁne tune model development and implementation and
formally measure and redress any disconnect between model
developers and model-users.
Finally, we see great potential for a new track of epidemic
modeling we have dubbed ‘outbreak science’ to improve public
health preparedness response. With sufﬁcient investment in the
development and growth of the ﬁeld, those trained in ‘outbreak
science’ will become vital contributors in helping public health
professionals navigate the many difﬁcult decisions that come with
infectious disease emergencies. Additionally, they will serve as a
key link between quantitative modelers and public health decision
makers in an era of increasing epidemic threats.
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